ETIOLOGIC ASPECTS OF INSULIN-DEPENDENT DIABETES-MELLITUS - AN EPIDEMIOLOGIC PERSPECTIVE

被引:21
作者
DAHLQUIST, G
机构
[1] Department of Pediatrics and Department of Epidemiology, University Hospital, Umea
关键词
INSULIN DEPENDENT DIABETES; ETIOLOGY; EPIDEMIOLOGY; RISK DETERMINANTS;
D O I
10.3109/08916939309004840
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mechanism of beta-cell destruction leading to insulin dependent diabetes is probably a cell mediated autoimmune process occurring in genetically susceptible individuals. Since 50-70% of monozygotic twins will not get the disease non-genetic risk factors must play an important role in the etiology of the disease. During the past decade population based epidemiological studies have identified several risk determinants for insulin dependent diabetes. Based on these studies a multifactorial hypothesis of causation is proposed. Some risk determinants (maternal child blood group incompatibility, fetal viral infections, early exposure to cow's milk proteins, a high exposure level of nitrosamines) may independently initiate the autoimmune process by causing the initial damage of the beta-cell, leading to antigen release. Other risk determinants may promote an already ongoing autoimmune destructive process through induction of lymphokine release or by causing an increased work load on the beta-cell. Risk factors that may increase the peripheral need for insulin (infectious diseases, cold environment, a high growth rate and stressful life events) may act as promoters of the beta-cell destruction but also disclose the beta-cell impairment and make the disease clinically overt. Possibilities of different risk profiles in different age groups and of synergism between different risk factors are also discussed.
引用
收藏
页码:61 / 65
页数:5
相关论文
共 43 条
  • [1] Eisenbarth G.S., Type 1 diabetes: A chronic autoimmune disease, N Eng J Med, 314, pp. 1360-1368, (1986)
  • [2] Bottazzo G.F., Pujol-Borrell R., Gale E.A.M., Autoimmunity and type 1 diabetes: Bringing the story up to date, The Diabetes Annual/3, pp. 15-38, (1987)
  • [3] Bottazzo G.F., Genovese S., Bosi E., Dean B.M., Christie M.R., Bonifacio E., Novel considerations on the antibody/autoantigen system in type 1 (insulin-dependent) diabetes mellitus, Ann Med, 23, pp. 453-461, (1991)
  • [4] Cyclosporin-induced remission of IDDM after early intervention: Association of 1 year of cyclosporin treatment with enhanced insulin secretion, Diabetes, 37, pp. 1574-1582, (1988)
  • [5] Deschamps J., Bevessi J.P., Khalu J., Robert J.J., Hors J., The role of genetic predisposition to type 1 (insulin-dependent) diabetes mellitus, Ann Med, 23, pp. 427-435, (1991)
  • [6] Pyke D.A., The genetic perspectives—putting research into practice, Diabetes 1988, pp. 1227-1230, (1989)
  • [7] Svejgaard A., Platz P., Ryder L.P., Insulin-dependent diabetes mellitus. Joint Report, Histocompatibility Testing, pp. 638-656, (1980)
  • [8] Nystrom L., DahlquistOstman G.J., Wall S., Arnqvist H., Blome G., Lithner F., Littorin B., Sodersten B., Wibell L., Developing diabetes before 35 years of age risk assessment based on a 5-year nationwide surveillance system, Int J Epid, 21, pp. 352-358, (1992)
  • [9] Mandrup-Poulsen T., On the pathogenesis of insulin-dependent diabetes mellitus, Dan Med Bull, 35, pp. 438-460, (1988)
  • [10] Nerup J., Mandrup-Poulsen T., Molvig J., Hedqvist S., Wogensen L., Egeberg J., Mechanisms of pancreatic B-cell destruction in type 1 diabetes, Diabetes Care, 11, pp. 16-23, (1988)